A 53-year-old woman chose the SMART REPORT Premium package after undergoing a routine blood test. She led a healthy lifestyle, exercised regularly, followed a balanced diet, and had no known chronic illnesses. Although she occasionally experienced chest discomfort, she had recently undergone a comprehensive cardiac evaluation, including echocardiography and an exercise stress test, both of which showed no abnormalities.
While analyzing her laboratory results, the SMART REPORT artificial intelligence detected a pattern suggestive of a rare disease. The system identified familial hypercholesterolemia (FH) as a condition she most likely has.
Familial hypercholesterolemia (FH) is an inherited genetic disorder that causes persistently elevated levels of low-density lipoprotein (LDL), commonly known as "bad" cholesterol, from an early age. If left untreated, FH significantly accelerates the development of atherosclerosis and increases the risk of premature heart attack, stroke, and other cardiovascular diseases.
Because the condition often remains completely symptom-free for many years, many affected individuals are only diagnosed after serious cardiovascular complications have already developed.
Despite the importance of early detection, according to the University of Debrecen, an estimated 30,000–40,000 people in Hungary are living with familial hypercholesterolemia, yet only 1–2% are aware that they have the disease.
SMART REPORT does not establish a medical diagnosis. Instead, its artificial intelligence compares a patient's laboratory results with hundreds of thousands of validated, anonymized laboratory records. By combining multiple mathematical and statistical models, it estimates which disease patterns most closely resemble the patient's laboratory profile.
When the system identifies a potential risk of a rare disease or cancer, this information is not automatically displayed in the patient's report. This is because such findings represent only a diagnostic hypothesis and could cause unnecessary anxiety if presented without proper medical interpretation.
Whenever SMART REPORT identifies a potential rare disease, the patient is contacted and offered a complimentary specialist consultation.
During the consultation, the physician carefully reviewed the patient's laboratory findings, previous medical examinations, lifestyle, and family medical history.
An important detail emerged during this discussion: both of the patient's parents had a history of elevated cholesterol levels, and her father had also developed heart disease. This family history strongly supported the diagnostic hypothesis generated by SMART REPORT.
Following the consultation, the physician recommended genetic testing at the University of Debrecen Clinical Centre and referral to the Lipid Clinic of the University of Pécs for comprehensive evaluation and long-term follow-up.
The patient followed these recommendations and attended the specialist lipid clinic, where further diagnostic investigations were initiated.
The detailed clinical evaluation, together with genetic testing, ultimately confirmed that the patient had familial hypercholesterolemia (FH).
Following the diagnosis, an individualized treatment plan was established within the lipid clinic to reduce her cardiovascular risk.
Only a few weeks after starting treatment, follow-up laboratory testing demonstrated a remarkable improvement. The patient's cholesterol levels had decreased substantially, and her laboratory values had begun to normalize.
This case demonstrates how early recognition of familial hypercholesterolemia, followed by appropriate treatment, can rapidly and effectively reduce cardiovascular risk.
Familial hypercholesterolemia is inherited in an autosomal dominant pattern, meaning that each child of an affected parent has approximately a 50% chance of inheriting the condition.
In this case, the patient's family history suggests that one—or possibly both—of her parents may also have had FH. Therefore, confirming the diagnosis was important not only for the patient herself but also because it enabled targeted screening of other family members, allowing treatment to begin if necessary.
When FH is identified early in life, affected relatives and children can receive regular monitoring, lifestyle guidance, and, when appropriate, treatment long before persistently elevated LDL cholesterol leads to atherosclerosis or serious cardiovascular complications.
Based on the lab results, SMART REPORT drew attention to a potential risk, which led to a targeted specialist evaluation. The family history revealed during the specialist consultation, combined with genetic testing, led to the diagnosis and, subsequently, to the appropriate treatment.
This story is a good example of how a single blood test can not only be a turning point for a patient but can also contribute to the detection of a hereditary disease, knowledge of which can be valuable for several generations of the family.
Innovation
